Search Results - "Nakatsu, Hiroomi"

Prognostic factors influencing overall survival in de novo oligometastatic prostate cancer patients by Rii, Junryo, Sakamoto, Shinichi, Yamada, Yasutaka, Takeshita, Nobushige, Yamamoto, Satoshi, Sazuka, Tomokazu, Imamura, Yusuke, Nakamura, Kazuyoshi, Komiya, Akira, Komaru, Atsushi, Fukasawa, Satoshi, Nakatsu, Hiroomi, Akakura, Koichiro, Ichikawa, Tomohiko

“…Background Oligometastatic cancer has been suggested as an intermediate state between localized disease and wide‐ranging metastases. The clinical significance…”
Get full text

Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients by Kanesaka, Manato, Sakamoto, Shinichi, Yamada, Yasutaka, Rii, Junryo, Maimaiti, Maihulan, Sazuka, Tomokazu, Imamura, Yusuke, Komiya, Akira, Akakura, Koichiro, Ikehara, Yuzuru, Nakatsu, Hiroomi, Ichikawa, Tomohiko

“…To identify the real high-risk group among Japanese de novo metastatic prostate cancer patients who fit CHAARTED or LATITUDE criteria. We retrospectively…”
Get full text

Treatment of locally advanced prostate cancer (Stage T3) by Amiya, Yoshiyasu, Yamada, Yasutaka, Sugiura, Masahiro, Sasaki, Makoto, Shima, Takayuki, Suzuki, Noriyuki, Nakatsu, Hiroomi, Murakami, Shino, Shimazaki, Jun

“…Formerly, locally advanced prostate cancer exhibited poorly prognosis. In the late 1990s, new surgical and radiation technologies were introduced in…”
Get full text

Kidney stone disease and risk factors for coronary heart disease by HAMANO, SATOSHI, NAKATSU, HIROOMI, SUZUKI, NORIYUKI, TOMIOKA, SUSUMU, TANAKA, MASASHI, MURAKAMI, SHINO

“…Background:  We conducted a case‐control study to examine the impact of coronal heart disease (CHD) risk factors on calcium oxalate (CaOX) stone formation…”
Get full text

Case of splenogonadal fusion in an adult by Ikeda, Atsushi, Nakatsu, Hiroomi, Suzuki, Yoshio

Get full text

Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients by Suzuki, Hiroyoshi, Komiya, Akira, Kamiya, Naoto, Imamoto, Takashi, Kawamura, Koji, Miura, Junichiro, Suzuki, Noriyuki, Nakatsu, Hiroomi, Hata, Akira, Ichikawa, Tomohiko

“…Several nomograms for prostate cancer detection have recently been developed. Because the incidence of prostate cancer is lower among Asian men, nomograms…”
Get full text

Significant prognostic difference between Grade Group 4 and 5 in the 2014 International Society of Urological Pathology Grading System for High Grade Prostate Cancer with Bone Metastasis by Yamada, Yasutaka, Sakamoto, Shinichi, Shimazaki, Jun, Sugiura, Masahiro, Amiya, Yoshiyasu, Sasaki, Makoto, Shima, Takayuki, Komiya, Akira, Suzuki, Noriyuki, Akakura, Koichiro, Ichikawa, Tomohiko, Nakatsu, Hiroomi

“…To investigate prognostic difference between Gleason Score (GS) 8 and 9–10, as the 2014 International Society of Urological Pathology Gleason Grading Systems…”
Get full text

Clinical outcomes by relative docetaxel dose and dose intensity as chemotherapy for Japanese patients with castration-resistant prostate cancer: a retrospective multi-institutional collaborative study by Kamiya, Naoto, Suzuki, Hiroyoshi, Ueda, Takeshi, Sato, Naohide, Nakatsu, Hiroomi, Mikami, Kazuo, Sato, Nobuo, Nomura, Kazushi, Akakura, Koichiro, Okano, Tatsuya, Ooki, Takemasa, Naya, Yukio, Ota, Sho, Masai, Motoyuki, Ichikawa, Tomohiko

“…Background The aim of this study was to retrospectively investigate clinical outcomes by relative dose and dose intensity of docetaxel (DOC) as chemotherapy…”
Get full text

Outcomes of patients older than 75 years with non-metastatic prostate cancer by Amiya, Yoshiyasu, Yamada, Yasutaka, Sugiura, Masahiro, Sasaki, Makoto, Shima, Takayuki, Suzuki, Noriyuki, Nakatsu, Hiroomi, Murakami, Shino, Shimazaki, Jun

“…Objective: Prostate cancer in elderly patients was formerly treated with androgen deprivation therapy. Since the latter of the 1990s new technologies were…”
Get full text

Intermittent androgen suppression for locally advanced and metastatic prostate cancer: Preliminary report of a prospective multicenter study by Sato, Naohide, Akakura, Koichiro, Isaka, Shigeo, Nakatsu, Hiroomi, Tanaka, Masashi, Ito, Haruo, Masai, Motoyuki

“…To clarify the effect of intermittent androgen suppression on the time to androgen-independent progression and changes in quality of life (QOL). Patients with…”
Get full text

Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL by Kawamura, Koji, Suzuki, Hiroyoshi, Kamiya, Naoto, Imamoto, Takashi, Yano, Masashi, Miura, Junichiro, Shimbo, Masaki, Suzuki, Noriyuki, Nakatsu, Hiroomi, Ichikawa, Tomohiko

“…Objectives:  Although several nomograms for prostate cancer detection have been developed for Western populations, the models constructed on Japanese data…”
Get full text

Clinical effect of naftopidil on the quality of life of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A prospective study by Komiya, Akira, Suzuki, Hiroyoshi, Awa, Yusuke, Egoshi, Ken-ichi, Onishi, Tetsuro, Nakatsu, Hiroomi, Ohki, Takemasa, Mikami, Kazuo, Sato, Naohide, Araki, Kazuhiro, Ota, Sho, Naya, Yukio, Ichikawa, Tomohiko

“…Objectives:  To investigate the benefit of α1‐adrenoceptor antagonist naftopidil on the quality of life (QOL) of patients with lower urinary tract symptoms…”
Get full text

Long-term outcomes of nonpalpable prostate cancer (T1c) patients treated with radical prostatectomy by Amiya, Yoshiyasu, Sasaki, Makoto, Shima, Takayuki, Tomiyama, Yuusuke, Suzuki, Noriyuki, Murakami, Shino, Nakatsu, Hiroomi, Shimazaki, Jun

“…Various strategies have been used to treat patients with nonpalpable prostate cancer (T1c). As one of the treatments for this stage, a radical prostatectomy…”
Get full text

Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: Using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey by SUZUKI, HIROYOSHI, YANO, MASASHI, AWA, YUSUKE, NAKATSU, HIROOMI, EGOSHI, KEN-ICHI, MIKAMI, KAZUO, OTA, SHO, OKANO, TATSUYA, HAMANO, SATORU, OHKI, TAKEMASA, FURUYA, YUZO, ICHIKAWA, TOMOHIKO

“…Aim: To examine the efficiency of α1‐blocker treatment on disease‐specific and generic quality of life (QOL) in men with clinically diagnosed benign prostatic…”
Get full text

Efficacy and safety of dutasteride on prostate cancer risk reduction in Asian men: the results from the REDUCE study by Akaza, Hideyuki, Kanetake, Hiroshi, Tsukamoto, Taiji, Miyanaga, Naoto, Sakai, Hideki, Masumori, Naoya, Nakatsu, Hiroomi, Sagiyama, Kazuyuki, Sakamoto, Sadaaki, Endo, Yukihiro, Yamanouchi, Takayoshi

“…A post hoc analysis of Asian men in the REDUCE study was conducted to investigate whether the outcomes were in line with those of the overall population…”
Get full text

Comparison of Gleason grade and score between preoperative biopsy and prostatectomy specimens in prostate cancer by TOMIOKA, SUSUMU, NAKATSU, HIROOMI, SUZUKI, NORIYUKI, MURAKAMI, SHINO, MATSUZAKI, OSAMU, SHIMAZAKI, JUN

“…Aim:  Although the histopathological findings obtained from biopsy specimens are important for choosing the appropriate management of prostate cancer, there…”
Get full text

Outcome of Patients with Localized Prostate Cancer Treated by Radiotherapy After Confirming the Absence of Lymph Node Invasion by Suzuki, Noriyuki, Shimbo, Masaki, Amiya, Yoshiyasu, Tomioka, Susumu, Shima, Takayuki, Murakami, Shino, Nakatsu, Hiroomi, Oota, Sayako, Shimazaki, Jun

“…Objective Management of lymph nodes in radiotherapy for prostate cancer is an issue for curative intent. To find the influence of lymph nodes, patients with…”
Get full text

PSA Doubling Time as a Predictive Factor on Repeat Biopsy for Detection of Prostate Cancer by Shimbo, Masashi, Tomioka, Susumu, Sasaki, Makoto, Shima, Takayuki, Suzuki, Noriyuki, Murakami, Shino, Nakatsu, Hiroomi, Shimazaki, Jun

“…Objective Detection of prostate cancer needs a biopsy of the prostate. Suspecting cancer from an increase in prostate-specific antigen (PSA) has a high…”
Get full text

Significance of prostate-specific antigen-doubling time on survival of patients with hormone refractory prostate cancer and bone metastasis: Analysis on 56 cases of cancer-specific death by Tomioka, Susumu, Shimbo, Masaki, Amiya, Yoshiyasu, Nakatsu, Hiroomi, Murakami, Shino, Shimazaki, Jun

“…Objective:  Most of the metastatic diseases initially respond to maximum androgen blockade, but then relapse and lose response, and finally die. After relapse,…”
Get full text

Outcome of Patients with Hormone-Refractory Prostate Cancer: Prognostic Significance of Prostate-Specific Antigen-Doubling Time and Nadir Prostate-Specific Antigen by Tomioka, Susumu, Shimbo, Masashi, Amiya, Yoshiyasu, Nakatsu, Hiroomi, Murakami, Shino, Shimazaki, Jun

“…Objective Most patients with advanced prostate cancer after prostate-specific antigen (PSA) relapse following maximum androgen blockade rapidly progress to…”
Get full text